Baishideng Publishing Group, World Journal of Gastroenterology, 26(20), p. 8709
Full text: Download
AIM: To determine the dose-related effects of a novel probiotic combination, I.31, on irritable bowel syndrome (IBS)-related quality of life (IBS-QoL).